| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024941271 |
| P356 | DOI | 10.1038/SJ.BMT.1705956 |
| P698 | PubMed publication ID | 18084334 |
| P2093 | author name string | J Apperley | |
| V Rocha | |||
| D Niederwieser | |||
| A Gratwohl | |||
| H Baldomero | |||
| K Frauendorfer | |||
| Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) | |||
| European Group for Blood and Marrow Transplantation EBMT (JACIE) | |||
| P2860 | cites work | A comparison of allografting with autografting for newly diagnosed myeloma | Q34577703 |
| Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling | Q34668125 | ||
| Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease | Q36059652 | ||
| Hematopoietic stem-cell transplantation | Q36461248 | ||
| Adult umbilical cord blood transplantation: a comprehensive review | Q36496725 | ||
| Donor selection for unrelated cord blood transplants | Q36558837 | ||
| Risk assessment in haematopoietic stem cell transplantation: stem cell source | Q36797773 | ||
| Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. | Q40644808 | ||
| Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia | Q44499780 | ||
| Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. | Q46917405 | ||
| EBMT activity survey 2004 and changes in disease indication over the past 15 years. | Q50783390 | ||
| Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years. | Q53558832 | ||
| Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia | Q58865943 | ||
| Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms | Q74554537 | ||
| Current trends in hematopoietic stem cell transplantation in Europe | Q74805731 | ||
| Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning | Q79233985 | ||
| Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe--impact of cost considerations | Q79801204 | ||
| Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies | Q80066587 | ||
| Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study | Q80459511 | ||
| Allografting or autografting for myeloma | Q80507211 | ||
| Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003 | Q81019308 | ||
| Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma | Q82192536 | ||
| P433 | issue | 8 | |
| P921 | main subject | stem cell transplantation | Q65592366 |
| P304 | page(s) | 687-705 | |
| P577 | publication date | 2007-12-17 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products | |
| P478 | volume | 41 |
| Q35042830 | A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells |
| Q46031355 | A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT. |
| Q37738589 | Allogeneic hematopoietic stem cell transplantation for adult acute lymphocytic leukemia |
| Q37315368 | Allogeneic or haploidentical HSCT for refractory or relapsed solid tumors in children: toward a neuroblastoma model |
| Q41066613 | Application of reticulated platelets to transfusion management during autologous stem cell transplantation |
| Q36093081 | Autologous cord blood harvesting in North Eastern Italy: ethical questions and emerging hopes for curing diabetes and celiac disease. |
| Q37649561 | Challenges in umbilical cord blood stem cell banking for stem cell reviews and reports |
| Q93128234 | Clinical and equipment-related factors associated with the adequate peripheral blood stem cell collection in autologous transplant at a tertiary cancer center in Kerala - A retrospective cohort study |
| Q44150277 | Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells |
| Q48585264 | Criteria for initiation and evaluation of minority donor programs and application to the example of donors of Turkish descent in Germany |
| Q24646497 | Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine |
| Q39877306 | Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial |
| Q56897007 | European survey on clinical use of cord blood for hematopoietic and non-hematopoietic indications |
| Q58041555 | GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation |
| Q56752696 | Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group |
| Q39054767 | Hematopoietic SCT in Iranian children 1991-2012. |
| Q45995264 | Immunohematopoietic stem cell transplantation in Cape Town: a ten-year outcome analysis in adults. |
| Q41070207 | Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution. |
| Q35106148 | Informed consent for cord blood donation. A theoretical and empirical study. |
| Q37334978 | Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study. |
| Q52905842 | Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial. |
| Q84091202 | Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions |
| Q50742848 | Management of related donor care: a European survey. |
| Q53384604 | Mycobacterium tuberculosis infection: a rare late complication after cord blood hematopoietic SCT. |
| Q47966106 | Optimal mobilization method and CD34+ dose calculation for autologous PBSC transplant in myeloma patients: two important unresolved questions |
| Q81631169 | Optimizing BM harvesting from normal adult donors |
| Q38815488 | Optimizing autologous cell grafts to improve stem cell gene therapy |
| Q50615811 | Prediction of duration and success rate of unrelated hematopoietic stem cell donor searches based on the patient's HLA-DRB1 allele and DRB1-DQB1 haplotype frequencies. |
| Q37313748 | Probability of parenthood after early onset cancer: a population-based study |
| Q31022472 | Quality control and assurance in hematopoietic stem cell transplantation data registries in Japan and other countries |
| Q37731525 | Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology |
| Q24626108 | Stem cell donation--what advice can be given to the donor? |
| Q33568824 | Stem cells derived from cord blood in transplantation and regenerative medicine |
| Q83557595 | Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program |
| Q83238029 | The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies |
| Q57515082 | The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation |
| Q36020073 | Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007. |
| Q36839332 | Twenty years of experience on stem cell transplantation in iran. |
| Q57515085 | UVA (UVA-1) therapy for the treatment of acute GVHD of the skin |
| Q35508338 | Umbilical Cord Blood Banking and Transplantation: A short review |
Search more.